Biopolitical Times

The Center for Genetics and Society blog highlights the latest developments in the social, political, and ethical implications of human biotechnologies, with contributions from staff, fellows, consultants, and guest authors.

Subscribe


Orchid test results

A brand-new, well-financed genome analysis company called Orchid made a splash last week:

Orchid Blooms With $4.5M Seed For Preconception Test To Determine Genetic Risks

(Kudos to the doubly punning headline writer at Crunchbase.) The concept is that Orchid will analyze “100% of both partners’ genomes” and analyze the possible ways they can combine “in a future child.” Thus future parents will be able to reduce the possibility that the child will suffer from “diseases like heart disease...

Biopolitical Times

It’s not for nothing that Time, Inc. developed its formula for telling stories—catchy lede, billboard that tells 'em what you’re going to tell ‘em, last graf that catapults them into the future. No wobbling; narrative charging right along. In the rush, the reader is propelled, questions cast aside, riding the tale you want them to believe.  

Not surprisingly, Walter Isaacson, bestselling author and former Time editor, has the style down pat. A sometimes breathless, technocratic enthusiasm; an ability to reduce...

At least five separate studies involving human embryo research are raising fresh versions of old questions about science, ethics and regulation. On March 17, Nature published two peer-reviewed papers about generating in vitro, with slightly different methods, “blastoids” or “human...

Photo by Michael on Unsplash

The Australian government is currently considering legalizing “mitochondrial donation,” also known as “3-person IVF.” Australian law currently prohibits creating embryos using DNA from more than two people. The prohibition is found in the...